Pihlajalinna (PIHLIS) CMD 2025 summary
Event summary combining transcript, slides, and related documents.
CMD 2025 summary
6 Jun, 2025Strategic direction and market outlook
Focus shifts increasingly to private healthcare services, with public sector collaboration expected to grow gradually.
Pihlajalinna positions itself as a committed partner for insurers, companies, and the public sector, aiming to be a healthcare reformer.
The company develops cost-effective care pathways to control partner costs and drive its own growth and profitability.
Technology and AI are leveraged to enhance customer and professional experiences and ensure efficient operations.
Emphasis on a people-centric work environment to attract and retain top healthcare professionals.
Financial guidance and targets
Medium-term targets: revenue at least €700 million, adjusted EBITA margin 12%, net debt/EBITDA below 2.5x.
Dividend policy remains: at least 1/3 of annual EPS, considering capital structure and funding needs.
Revenue expected to decrease by €115 million in 2026 due to expiring outsourcing contracts, but private services are growing faster than the market.
Insurance partner sales have grown at a 25% CAGR from 2022–2024.
Ongoing measures to strengthen profitability include pricing, process improvements, and expanding service offerings.
Business development and innovation
Develops integrated, value-based care pathways using AI-driven tools for need-based customer guidance.
Focus on partnerships with insurers, companies, and the public sector to co-create solutions and optimize care delivery.
Digital services and automation are prioritized to improve efficiency and customer experience.
Demonstrated ability to deliver cost-effective outsourcing and public sector solutions, with proven customer satisfaction (NPS 79–98).
Operates in a growing market, with private and public healthcare segments expected to grow 3–4% annually through 2030.
Latest events from Pihlajalinna
- Record profitability in 2025 despite 7.4% revenue drop; 2026 outlook remains cautious.PIHLIS
Q4 202512 Feb 2026 - Profitability rose in Q3 2025 with higher EPS, despite lower revenue and sector headwinds.PIHLIS
Q3 202531 Oct 2025 - Profitability and margins rose in H1 2025, led by Private Healthcare Services growth.PIHLIS
Q2 202524 Jul 2025 - Profitability and organic growth strengthened, with upgraded 2024 EBITA guidance to €53–56m.PIHLIS
Q3 202413 Jun 2025 - Profitability and cash flow surged, with upgraded profit guidance despite revenue decline.PIHLIS
Q2 202413 Jun 2025 - Record profitability and strong organic growth support a positive margin outlook for 2025.PIHLIS
Q4 20245 Jun 2025 - Record profit growth and margin expansion led by Private Healthcare Services.PIHLIS
Q1 20255 Jun 2025